NeuroPointDX Presented Poster at IMFAR 2017: Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP)
Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP)
NeuroPointDX is conducting a research study called Children’s Autism Metabolome Project (CAMP), which is the largest autism-specific clinical study using metabolomics-based methodologies. Metabolism-based analysis has the potential to identify biomarker profiles, derived from an individual’s inherited biochemistry, as well as capture the interactions of the gut microbiome, dietary, and environmental factors that contribute to the unique metabolic signature of an individual with autism spectrum disorder. Dr. Robert Burrier presented this poster at the International Meeting for Autism Research, May 2017.
Please fill out the form below to download the poster:
- The NPDX AA test can identify ~30% of children with #autism spectrum disorder (ASD) with an increased risk of an AS… https://t.co/R1s2P7oIdB4 hours ago
- The holidays, which can be overstimulating even for neurotypical people, are coming soon. Adults with #autism think… https://t.co/PSA0EFahUn7 hours ago
- Save yourself a phone call – learn from the list of questions and answers about the NPDX AA test, written to addres… https://t.co/UcVH5ssk0119 hours ago